Stefan Kittler

Mr. Stefan Kittler


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2022 in Fermentation
Verified
Journal Article
Open access
PDF file
TGThomas Gundinger
Thomas Gundinger
SKStefan Kittler
Stefan Kittler
SKSabine Kubicek
Sabine Kubicek
JKJulian Kopp
Julian Kopp
OSOliver Spadiut
Oliver Spadiut
Auto-inducible promoter systems have been reported to increase soluble product formation in the periplasm of E. coli compared to inducer-dependent systems. In this study, we investigated the phosphate (PO4)-sensitive phoA expression system (pAT) for the production of a recombinant model antigen-binding fragment (Fab) in the periplasm of E. coli in detail. We explored the impact of non-limiting and limiting PO4 conditions on strain physiology as well as Fab productivity. We compared different methods for extracellular PO4 detection, identifying automated colorimetric measurement to be most suitable for at-line PO4 monitoring. We showed that PO4 limitation boosts phoA-based gene expression, however, the product was already formed at non-limiting PO4 conditions, indicating leaky expression. Furthermore, cultivation under PO4 limitation caused physiological changes ultimately resulting in a metabolic breakdown at PO4 starvation. Finally, we give recommendations for process optimization with the phoA expression system. In summary, our study provides very detailed information on the E. coli phoA expression system, thus extending the existing knowledge of this system, and underlines its high potential for the successful production of periplasmic products in E. coli.

17 May 2021 in Processes
Verified
Journal Article
Open access
PDF file
SKStefan Kittler
Stefan Kittler
MBMihail Besleaga
Mihail Besleaga
JEJulian Ebner
Julian Ebner
OSOliver Spadiut
Oliver Spadiut
In the past 30 years, highly specific drugs, known as antibodies, have conquered the biopharmaceutical market. In addition to monoclonal antibodies (mAbs), antibody fragments are successfully applied. However, recombinant production faces challenges. Process analytical tools for monitoring and controlling production processes are scarce and time-intensive. In the downstream process (DSP), affinity ligands are established as the primary and most important step, while the application of other methods is challenging. The use of these affinity ligands as monitoring tools would enable a platform technology to monitor process steps in the USP and DSP. In this review, we highlight the current applications of affinity ligands (proteins A, G, and L) and discuss further applications as process analytical tools.

4 October 2022 in Journal of Biotechnology
Verified
Journal Article
Open access
SKStefan Kittler
Stefan Kittler
JEJulian Ebner
Julian Ebner
MBMihail Besleaga
Mihail Besleaga
JLJohan Larsbrink
Johan Larsbrink
BDBarbara Darnhofer
Barbara Darnhofer
OSOliver Spadiut
Oliver Spadiut
Protein L (PpL) is a universal binding ligand that can be used for the detection and purification of antibodies and antibody fragments. Due to the unique interaction with immunoglobulin light chains, it differs from other affinity ligands, like protein A or G. However, due to its current higher market price, PpL is still scarce in applications. In this study, we investigated the recombinant production and purification of PpL and characterized the product in detail. We present a comprehensive roadmap for the production of the versatile protein PpL in E. coli.